Papers
1
Total Citations
2
H-Index
1
About
Ming Du is a pioneering figure in gynecologic oncology and robotic surgery, best known for advancing the clinical validation of domestic surgical robotic systems. His research focuses on the comparative effectiveness and safety of novel robotic platforms in complex oncologic procedures, particularly for endometrial cancer. Du’s landmark work, the multi-center, randomized, noninferiority trial comparing the KangDuo Surgical Robot-01 (KD-SR-01) with the da Vinci Xi system, represents a major contribution to the field. This study provides rigorous evidence that the KD-SR-01 is both safe and effective for endometrial cancer staging, challenging the dominance of established international systems and paving the way for broader adoption of cost-effective robotic alternatives. While his most-cited paper currently has 2 citations, its publication in 2025 signals emerging impact in a rapidly evolving area. Du’s work is instrumental in shaping the future of minimally invasive surgery, offering hope for expanded access to robotic-assisted care worldwide. His dedication to high-quality, comparative trials underscores his role as a leader in surgical innovation and health equity.
Research Focus
Key Achievements
Top Papers
- 1